Expanding Clinical Trials

Metronomic chemotherapy

Chemotherapy typically involves maximum tolerated doses. These high doses cause severe adverse effects and morbidity. Metronomic dosing of chemotherapy is generally better tolerated and may also be more effective at reducing tumor burden.

What is the research problem

Sequential metronomic chemotherapy is not widely utilized by Medical Oncologists due to not having been studied in many clinical trials.

How will your solution make a difference

We have found that sequential metronomic dosing effectively decreasing the burden of disease with more manageable adverse effects. Research into metronomic chemotherapy may eventually benefit patients' quality of life and treatment outcomes.

What is your proposed solution

More funding and attention needs to be given to perform clinical trials assessing the efficacy of metronomic chemotherapy.

Voting

0 votes
Ideate
Idea No. 745

Attachments

- Show all